US BANCORP \DE\ - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is and the CUSIP is 74754R202. A total of 15 filers reported holding QUALIGEN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$832
+10.8%
8240.0%0.00%
Q2 2023$751
-1.4%
8240.0%0.00%
Q1 2023$762
+56.8%
824
+118.6%
0.00%
Q4 2022$4863770.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 8,009$10,3240.01%
Virtu Financial LLC 10,461$140.00%
ICA Group Wealth Management, LLC 245$3160.00%
ROYAL BANK OF CANADA 4$00.00%
VANGUARD GROUP INC 95,681$123,3330.00%
UBS Group AG 2,192$2,8270.00%
US BANCORP \DE\ 377$4860.00%
WELLS FARGO & COMPANY/MN 26$340.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,256$1,6450.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders